blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3572423

EP3572423 - ANTI-HUMAN PAPILLOMAVIRUS 16 E6 T CELL RECEPTORS [Right-click to bookmark this link]
StatusThe patent has been granted
Status updated on  03.11.2023
Database last updated on 24.04.2024
FormerGrant of patent is intended
Status updated on  13.06.2023
FormerExamination is in progress
Status updated on  11.02.2022
FormerRequest for examination was made
Status updated on  29.05.2020
FormerThe application has been published
Status updated on  25.10.2019
Most recent event   Tooltip19.04.2024Lapse of the patent in a contracting state
New state(s): BG, LT
published on 22.05.2024 [2024/21]
Applicant(s)For all designated states
The United States of America, as represented by the Secretary, Department of Health and Human Services
Office of Technology Transfer
National Institutes of Health
6701 Rockledge Drive, Suite 700, MSC 7788
Bethesda, Maryland 20892-7788 / US
[2023/48]
Former [2019/48]For all designated states
The U.S.A. as represented by the Secretary, Department of Health and Human Services
Office of Technology Transfer
National Institutes of Health
6011 Executive Boulevard, Suite 325
MSC 7660
Bethesda, MD 20892-7660 / US
Inventor(s)01 / HINRICHS, Christian S.
5814 Melvern Drive
Bethesda, MD 20817 / US
02 / ROSENBERG, Steven A.
10104 Iron Gate Road
Potomac, MD 20854 / US
 [2019/48]
Representative(s)Maiwald GmbH
Elisenhof
Elisenstraße 3
80335 München / DE
[2023/49]
Former [2019/48]Huenges, Martin
Maiwald Patentanwalts- und
Rechtsanwaltsgesellschaft mbH
Elisenhof
Elisenstraße 3
80335 München / DE
Application number, filing date19180239.614.07.2014
[2019/48]
Priority number, dateUS201361846167P15.07.2013         Original published format: US 201361846167 P
[2019/48]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3572423
Date:27.11.2019
Language:EN
[2019/48]
Type: B1 Patent specification 
No.:EP3572423
Date:06.12.2023
Language:EN
[2023/49]
Search report(s)(Supplementary) European search report - dispatched on:EP19.08.2019
ClassificationIPC:C07K14/725
[2019/48]
CPC:
C07K14/7051 (EP,US); A61K35/17 (US); A61K39/4611 (EP);
A61K39/4632 (EP); A61K39/464491 (EP); A61K39/464838 (EP);
A61P31/20 (EP); A61P35/00 (EP); C07K16/2809 (US);
G01N33/566 (US); A61K38/00 (EP,US); C07K2317/34 (US);
C07K2319/00 (EP,US); G01N2333/7051 (US); G01N2800/7028 (US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/27]
Former [2019/48]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
TitleGerman:T-ZELL-REZEPTOREN GEGEN MENSCHLICHES PAPILLOMAVIRUS 16 E6[2019/48]
English:ANTI-HUMAN PAPILLOMAVIRUS 16 E6 T CELL RECEPTORS[2019/48]
French:RÉCEPTEURS DE LYMPHOCYTES T ANTI-PAPILLOMAVIRUS HUMAIN 16 E6[2019/48]
Examination procedure22.05.2020Amendment by applicant (claims and/or description)
22.05.2020Examination requested  [2020/27]
22.05.2020Date on which the examining division has become responsible
15.02.2022Despatch of a communication from the examining division (Time limit: M02)
07.04.2022Reply to a communication from the examining division
14.06.2023Communication of intention to grant the patent
23.10.2023Fee for grant paid
23.10.2023Fee for publishing/printing paid
23.10.2023Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP14748353.1  / EP3022223
Fees paidRenewal fee
14.06.2019Renewal fee patent year 03
14.06.2019Renewal fee patent year 04
14.06.2019Renewal fee patent year 05
29.07.2019Renewal fee patent year 06
27.07.2020Renewal fee patent year 07
27.07.2021Renewal fee patent year 08
27.07.2022Renewal fee patent year 09
27.07.2023Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipLT06.12.2023
BG06.03.2024
GR07.03.2024
[2024/21]
Former [2024/20]GR07.03.2024
Documents cited:Search[A]WO2007131092  (US GOV HEALTH & HUMAN SERV [US], et al) [A] 1-15* example -; claim - *;
 [A]  - SCHOLTEN K B J ET AL, "Promiscuous behavior of HPV16E6 specific T cell receptor beta chains hampers functional expression in TCR transgenic T cells, which can be restored in part by genetic modification", CELLULAR ONCOLOGY, IOS PRESS, LONDON, GB, (20100101), vol. 32, no. 1-2, ISSN 1570-5870, pages 43 - 56, XP009180698 [A] 1-15 * abstract; results; discussion; page 44, column r, paragraph 3 * * page 54, column l, paragraph 2 *
 [A]  - LYONS G E, "Immunotherapeutic strategies against human papillomavirus induced cervical cancer", DISSERTATION,, (200412), page 157pp, XP009180711 [A] 1-15 * page 79, paragraph 2 - page 103, paragraph 1; figures 17-30 *
by applicantEP0239400
 GB2188638
 US5087616
 US5225539
 US5449752
 US5545806
 US5569825
 US5585089
 US5639641
 US5693761
 US5714352
 US6265150
 US2002197266
 US8034334
 US2012244133
 US8383099
    - CHOI et al., Mol. Biotechnol., (20050000), vol. 31, pages 193 - 202
    - HUDECZ, F., Methods Mol. Biol., (20050000), vol. 298, pages 209 - 223
    - PEDERSEN et al., J. Mol. Biol., (19940000), vol. 235, pages 959 - 973
    - KIRIN et al., Inorg Chem., (20050000), vol. 44, no. 15, pages 5405 - 5415
    - DUDLEY et al., J. Immunother., (20030000), vol. 26, pages 332 - 42
    - RIDDELL et al., J. Immunol. Methods, (19900000), vol. 128, pages 189 - 201
    - KOHLERMILSTEIN, Eur. J. Immunol., (19760000), vol. 5, pages 511 - 519
    - HASKARDARCHER, J. Immunol. Methods, (19840000), vol. 74, no. 2, pages 361 - 67
    - RODER et al., Methods Enzymol., (19860000), vol. 121, pages 140 - 67
    - HUSE et al., Science, (19890000), vol. 246, pages 1275 - 81
    - REITER et al., Protein Engineering, (19940000), vol. 7, pages 697 - 704
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.